pathway

glymphatic clearance

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about glymphatic clearance: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

97Connections

4Hypotheses

14Analyses

16Outgoing

50Incoming

0Experiments

20Debates

No summary available yet.

View on Wiki →

No AI portrait yet

🔀 Pathway Info

Name	glymphatic clearance
Key Genes/Proteins	ALS, APOE, APOE4, APP, AQP1, AQP4
Related Diseases	Alzheimer's disease
Linked Hypotheses	11 hypotheses

Pathway Diagram

graph TD
    glymphatic_clearance["glymphatic clearance"] -->|"active in"| astrocytes["astrocytes"]
    style astrocytes fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    glymphatic_clearance["glymphatic clearance"] -->|"active in"| cortex["cortex"]
    style cortex fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    glymphatic_clearance["glymphatic clearance"] -->|"active in"| macrophages["macrophages"]
    style macrophages fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    glymphatic_clearance["glymphatic clearance"] -->|"active in"| blood_brain_barrier["blood-brain barrier"]
    style blood_brain_barrier fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    glymphatic_clearance["glymphatic clearance"] -->|"active in"| endothelial_cells["endothelial cells"]
    style endothelial_cells fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    glymphatic_clearance["glymphatic clearance"] -->|"active in"| dopaminergic_neurons["dopaminergic neurons"]
    style dopaminergic_neurons fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#fff
    AQP4["AQP4"] -->|"participates in"| glymphatic_clearance["glymphatic clearance"]
    style AQP4 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
    Alzheimer_s_disease["Alzheimer's disease"] -->|"involves"| glymphatic_clearance["glymphatic clearance"]
    style Alzheimer_s_disease fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    neurodegeneration["neurodegeneration"] -->|"involves"| glymphatic_clearance["glymphatic clearance"]
    style neurodegeneration fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    neuroinflammation["neuroinflammation"] -->|"involves"| glymphatic_clearance["glymphatic clearance"]
    style neuroinflammation fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    traumatic_brain_injury["traumatic brain injury"] -->|"involves"| glymphatic_clearance["glymphatic clearance"]
    style traumatic_brain_injury fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#fff
    style glymphatic_clearance fill:#1b5e20,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold

Outgoing (16)

Target	Relation	Type	Str
Alzheimer disease	associated_with	disease	0.90
Amyloid Clearance	involved_in	process	0.80
astrocytes	active_in	cell_type	0.80
tau_pathology	associated_with	disease	0.70
neurodegeneration	protective_against	disease	0.70
NEURODEGENERATION	causes	disease	0.65
NEURODEGENERATION	exacerbates	disease	0.65
TAU	activates	protein	0.65
AQP4	interacts_with	gene	0.65
dopaminergic neurons	active_in	cell_type	0.60
blood-brain barrier	active_in	brain_region	0.60
cortex	active_in	brain_region	0.60
macrophages	active_in	cell_type	0.60
endothelial cells	active_in	cell_type	0.60
FRONTAL CORTEX	associated_with	brain_region	0.45
CORTEX	associated_with	brain_region	0.45

Incoming (81)

Source	Relation	Type	Str
AQP4	mediates	protein	0.95
AQP4	participates_in	gene	0.90
TDP-43	associated_with	protein	0.90
slow_wave_sleep	enhances	phenotype	0.90
sleep-wake regulation	associated_with	pathway	0.90
slow-wave sleep	regulates	process	0.90
circadian rhythm	associated_with	phenotype	0.90
AQP4	regulates	protein	0.90
slow-wave_sleep	activates	phenotype	0.90
CSF FLOW	activates	phenotype	0.90
sleep/wake regulation	associated_with	pathway	0.90
sleep deprivation	reduces	process	0.90
Alzheimer's disease	involves	disease	0.90
AQP4	regulates	protein	0.80
neurodegeneration	involves	disease	0.80
astrocytes	active_in	cell_type	0.75
PS1	participates_in	gene	0.75
ALS	participates_in	gene	0.70
nocturnal noradrenergic tone	inhibits	process	0.70
Slow-wave sleep	enhances	process	0.70
Nocturnal noradrenergic tone	inhibits	process	0.70
AQP4 mislocalization	inhibits	process	0.70
Sleep	regulates	gene	0.70
AQP4	modulates	protein	0.70
slow-wave sleep	enhances	process	0.70
OX1R/OX2R antagonism	activates	drug	0.70
sleep architecture	modulates	process	0.70
neuroinflammation	involves	disease	0.70
AQP4	facilitates	gene	0.70
gamma oscillations at 40Hz	enhances	mechanism	0.70
sleep deprivation	inhibits	process	0.70
sleep	activates	process	0.70
AQP4	regulates	gene	0.70
age_related_melatonin_decline	associated_with	phenotype	0.70
AQP4 Polarization	associated_with	phenotype	0.70
norepinephrine withdrawal	enhances	phenotype	0.70
AQP4 dysregulation	associated_with	phenotype	0.70
mitochondrial transfer	associated_with	mechanism	0.70
mitochondrial DNA release	associated_with	mechanism	0.65
AQP4	activates	gene	0.65
AQP4	inhibits	gene	0.65
APOE	participates_in	gene	0.65
APOE4	participates_in	gene	0.65
GABA	participates_in	gene	0.60
P2Y12	participates_in	gene	0.60
CK2	participates_in	gene	0.60
GBA	participates_in	gene	0.60
PERK	participates_in	gene	0.60
traumatic brain injury	involves	disease	0.60
ERK1	participates_in	gene	0.60

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Sleep-Dependent Glymphatic Clearance Expands the Therapeutic	0.780	neurodegeneration	What is the therapeutic window between t
Closed-loop orexin receptor modulation to entrain circadian	0.533	neurodegeneration	-
Targeting AQP4 Sumoylation to Enhance Glymphatic Clearance a	0.490	neurodegeneration	What are the specific molecular mechanis
Gamma Restoration Reduces Tau via Glymphatic Clearance	0.250	Alzheimer's disease	Closed-loop transcranial focused ultraso

Mentioning Analyses (14)

Scientific analyses that reference this entity

What is the optimal dosage and timing of melatonin administration for AD prevent

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.735

Orexin-A manipulation in AD cognition and circadian dysfunction

neurodegeneration | 2026-04-26 | 3 hypotheses Top: 0.758

What is the temporal sequence of sleep disruption versus amyloid-beta accumulati

neurodegeneration | 2026-04-12 | 0 hypotheses

How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pa

neurodegeneration | 2026-04-08 | 1 hypotheses Top: 0.390

How can AQP4 be effectively targeted therapeutically to improve neurological out

neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.690

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (5)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025
Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810]	["Chen Kai", "Li Fuyao", "Zhang Shuwen",	Journal of neuroinflammation	2025
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020
Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554]	Marogianni C, Sokratous M, Dardiotis E,	International journal of molec	2020
Multiple Sclerosis Pathology. [PMID:29358320]	Lassmann H	Cold Spring Harbor perspective	2018

Debates (20)

Multi-agent debates referencing this entity

Extended debate: Closed-loop transcranial focused ultrasound with 40Hz gamma ent

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Extended debate: Closed-loop tACS targeting EC-II SST interneurons to block tau

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound targeting entorhinal PV inte

closed · Rounds: 4 · Score: 0.65 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II SST interneurons to block tau propagati

closed · Rounds: 4 · Score: 0.71 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound to restore hippocampal gamma

closed · Rounds: 4 · Score: 0.87 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II PV interneurons to suppress burst firin

closed · Rounds: 4 · Score: 0.48 · 2026-04-27

Debate: Closed-loop tACS targeting EC-II somatostatin interneurons to restore de

closed · Rounds: 4 · Score: 0.54 · 2026-04-27

Debate: Closed-loop transcranial focused ultrasound with real-time gamma feedbac

closed · Rounds: 4 · Score: 0.19 · 2026-04-27

Hypothesis debate: Closed-loop transcranial alternating current stimulation to r

closed · Rounds: 4 · Score: 0.40 · 2026-04-27

Hypothesis debate: Closed-loop transcranial focused ultrasound to restore hippoc

closed · Rounds: 4 · Score: 0.50 · 2026-04-27

Related Research

Hypotheses and analyses mentioning glymphatic clearance in their description or question text

No additional research found